Weight Loss Drug Lawsuits 2026, FDA Warnings and New Vision Loss and Stomach Paralysis Claims January 2026 Update
As of January 2026, thousands of lawsuits are actively moving through U.S. courts against the manufacturers of popular GLP-1 weight loss medications like Ozempic, Wegovy, and Mounjaro. Plaintiffs allege that companies failed to warn about severe risks, including gastroparesis (stomach paralysis) and a newly emerging litigation focus on permanent vision loss (NAION). Current Status of…
